Literature DB >> 18165904

Chronic pediatric inflammatory diseases: effects on bone.

Anuradha Viswanathan1, Francisco A Sylvester.   

Abstract

In children, chronic inflammatory diseases present a significant challenge to long-term skeletal health. These conditions are often associated with poor appetite and suboptimal overall nutrition, altered nutrient utilization, delayed puberty, inactivity, and reduced muscle mass, all of which can alter bone metabolism. In addition, bone cell activity is susceptible to the effects of the immune response that characterizes these diseases. Moreover, drugs used to treat these maladies, notably glucocorticoids, may have negative effects on bone formation and on linear growth in developing children. As a result, predicted peak bone mass may not be achieved, and fracture risk may be increased in the short term or in the future. Studies using primarily dual energy X-ray absorptiometry have documented that deficits in bone mass are common in these diseases. However, there are wide variations in the prevalence of low bone mass, largely due to differences in the characteristics of each study population. Recent studies provide insight into the pathogenesis of decreased bone mass in these conditions. In this paper we will provide an overview of the effects of chronic inflammatory conditions on bone mass in children. We will also present relevant data from adult patients, when pediatric data are scant or not available.

Entities:  

Mesh:

Year:  2007        PMID: 18165904     DOI: 10.1007/s11154-007-9070-0

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN: 1389-9155            Impact factor:   6.514


  206 in total

1.  Failure of high-dose ergocalciferol to correct vitamin D deficiency in adults with cystic fibrosis.

Authors:  Michael P Boyle; Michelle L Noschese; Sharon L Watts; Marsha E Davis; Shane E Stenner; Noah Lechtzin
Journal:  Am J Respir Crit Care Med       Date:  2005-04-28       Impact factor: 21.405

2.  Therapy of osteoporosis in patients with Crohn's disease: a randomized study comparing sodium fluoride and ibandronate.

Authors:  C von Tirpitz; J Klaus; M Steinkamp; L C Hofbauer; W Kratzer; R Mason; B O Boehm; G Adler; M Reinshagen
Journal:  Aliment Pharmacol Ther       Date:  2003-03-15       Impact factor: 8.171

3.  Low bone mineral density in young children with cystic fibrosis.

Authors:  Isabelle Sermet-Gaudelus; Jean Claude Souberbielle; Jean Charles Ruiz; Stephanie Vrielynck; Blandine Heuillon; Imrana Azhar; Aline Cazenave; Ethel Lawson-Body; Frédérique Chedevergne; Gérard Lenoir
Journal:  Am J Respir Crit Care Med       Date:  2007-02-01       Impact factor: 21.405

4.  Understanding the IL-23-IL-17 immune pathway.

Authors:  Brent S McKenzie; Robert A Kastelein; Daniel J Cua
Journal:  Trends Immunol       Date:  2005-11-14       Impact factor: 16.687

5.  Diminished and erratic absorption of ergocalciferol in adult cystic fibrosis patients.

Authors:  R K Lark; G E Lester; D A Ontjes; A D Blackwood; B W Hollis; M M Hensler; R M Aris
Journal:  Am J Clin Nutr       Date:  2001-03       Impact factor: 7.045

6.  Inflammatory bowel disease and predisposition to osteopenia.

Authors:  F J Cowan; J T Warner; F D Dunstan; W D Evans; J W Gregory; H R Jenkins
Journal:  Arch Dis Child       Date:  1997-04       Impact factor: 3.791

7.  Analysis of the structure and strength of bones in celiac disease patients.

Authors:  José Ferretti; Roberto Mazure; Patricio Tanoue; Alicia Marino; Gustavo Cointry; Horacio Vazquez; Sonia Niveloni; Silvia Pedreira; Eduardo Mauriño; José Zanchetta; Julio C Bai
Journal:  Am J Gastroenterol       Date:  2003-02       Impact factor: 10.864

8.  Hidden depletion of fat-free mass and bone mineral density in adults with cystic fibrosis.

Authors:  Alina A Ionescu; William D Evans; Rebecca J Pettit; Lisette S Nixon; Michael D Stone; Dennis J Shale
Journal:  Chest       Date:  2003-12       Impact factor: 9.410

9.  Effects of nutritional supplementation on bone mineral status of children with rheumatic diseases receiving corticosteroid therapy.

Authors:  B D Warady; C B Lindsley; F G Robinson; B P Lukert
Journal:  J Rheumatol       Date:  1994-03       Impact factor: 4.666

Review 10.  The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models.

Authors:  Erik Lubberts; Marije I Koenders; Wim B van den Berg
Journal:  Arthritis Res Ther       Date:  2004-11-30       Impact factor: 5.156

View more
  10 in total

Review 1.  Inflammatory bone loss: pathogenesis and therapeutic intervention.

Authors:  Kurt Redlich; Josef S Smolen
Journal:  Nat Rev Drug Discov       Date:  2012-03-01       Impact factor: 84.694

2.  Assessment of bone remodelling in childhood-onset systemic lupus erythematosus.

Authors:  Julie C Baker-LePain; Mary C Nakamura; John Shepherd; Emily von Scheven
Journal:  Rheumatology (Oxford)       Date:  2010-11-23       Impact factor: 7.580

3.  Bone impairment assessed by HR-pQCT in juvenile-onset systemic lupus erythematosus.

Authors:  J A Paupitz; G L Lima; J C Alvarenga; R M Oliveira; E Bonfa; R M R Pereira
Journal:  Osteoporos Int       Date:  2015-12-22       Impact factor: 4.507

Review 4.  Smurf control in bone cells.

Authors:  Lianping Xing; Ming Zhang; Di Chen
Journal:  J Cell Biochem       Date:  2010-06-01       Impact factor: 4.429

5.  Bone status in adults with early-onset juvenile idiopathic arthritis following 1-year anti-TNFα therapy and discontinuation of glucocorticoids.

Authors:  Kristyna Brabnikova Maresova; Katerina Jarosova; Karel Pavelka; Jan J Stepan
Journal:  Rheumatol Int       Date:  2013-02-01       Impact factor: 2.631

Review 6.  Pathological fractures in paediatric patients with inflammatory bowel disease.

Authors:  Sze Choong Wong; A G Anthony Catto-Smith; Margaret Zacharin
Journal:  Eur J Pediatr       Date:  2013-10-17       Impact factor: 3.183

7.  Secondary osteoporosis in patients with juvenile idiopathic arthritis.

Authors:  Kristyna Brabnikova Maresova
Journal:  J Osteoporos       Date:  2011-02-20

Review 8.  The impact of inflammation on bone mass in children.

Authors:  Wai W Cheung; Jian-Ying Zhan; Kyung Hoon Paik; Robert H Mak
Journal:  Pediatr Nephrol       Date:  2011-01-01       Impact factor: 3.714

9.  Is it necessary to screen for celiac disease in adult idiopathic osteoporosis?

Authors:  Bijan Shahbazkhani; Najmeh Aletaha; Ahmad Khonche; Benyamin Farahvash; Reza Malekzadeh
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2015

10.  Children with nephrotic syndrome have greater bone area but similar volumetric bone mineral density to healthy controls.

Authors:  R J Moon; R D Gilbert; A Page; L Murphy; P Taylor; C Cooper; E M Dennison; J H Davies
Journal:  Bone       Date:  2013-10-18       Impact factor: 4.398

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.